When is steatosis too much for transplantation?

[1]  Erick M Remer,et al.  The utility of radiological imaging in nonalcoholic fatty liver disease. , 2002, Gastroenterology.

[2]  S. Uemoto,et al.  Effects of fatty infiltration of the graft on the outcome of living-related liver transplantation. , 1999, Transplantation proceedings.

[3]  P. Clavien,et al.  Understanding the meaning of fat in the liver , 2005, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[4]  R. Busuttil,et al.  The utility of marginal donors in liver transplantation , 2003, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[5]  P. Friend,et al.  Current practice regarding the use of fatty livers: A Trans‐Atlantic survey , 2002, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[6]  T. Fishbein,et al.  Use of livers with microvesicular fat safely expands the donor pool. , 1997, Transplantation.

[7]  S. Fan,et al.  Safety of donors in live donor liver transplantation using right lobe grafts. , 2000, Archives of surgery.

[8]  Ja-june Jang,et al.  The hepatic regeneration power of mild steatotic grafts is not impaired in living‐donor liver transplantation , 2005, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[9]  M. Charlton.  Nonalcoholic fatty liver disease: a review of current understanding and future impact. , 2004, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[10]  M. Morino,et al.  The outcome of steatotic grafts in liver transplantation. , 1991, Transplantation proceedings.

[11]  M. Yamagata,et al.  Role of eicosapentaenoic acid in lipid metabolism in the liver, with special reference to experimental fatty liver. , 1994, Clinical therapeutics.

[12]  R. Calne,et al.  Liver transplantation: the recent Cambridge-King's College Hospital experience. , 1987, Clinical transplants.

[13]  N. Selzner,et al.  Protective strategies against ischemic injury of the liver. , 2003, Gastroenterology.

[14]  J. Briceño,et al.  Assignment of steatotic livers by the Mayo model for end‐stage liver disease , 2005, Transplant international : official journal of the European Society for Organ Transplantation.

[15]  C. Ryan,et al.  One hundred consecutive hepatic biopsies in the workup of living donors for right lobe liver transplantation , 2002, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[16]  M A Ureña,et al.  Assessing risk of the use of livers with macro and microsteatosis in a liver transplant program. , 1998, Transplantation proceedings.

[17]  N. L. Johnson,et al.  Multivariate Analysis , 1958, Nature.

[18]  G. Ramadori,et al.  Is a fatty liver dangerous for transplantation? , 1999, Transplantation proceedings.

[19]  S. Jang,et al.  The effect of donor weight reduction on hepatic steatosis for living donor liver transplantation , 2004, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[20]  Ali H Mokdad,et al.  Increasing prevalence of the metabolic syndrome among u.s. Adults. , 2004, Diabetes care.

[21]  M. Stegall,et al.  Risk factors for primary dysfunction after liver transplantation--a multivariate analysis. , 1993, Transplantation.

[22]  W. Jochum,et al.  Mouse livers with macrosteatosis are more susceptible to normothermic ischemic injury than those with microsteatosis. , 2006, Journal of hepatology.

[23]  P. Clavien.  Third forum on liver transplantation. Living donor liver transplantation. Who needs it? How to do it? Who should do it? , 2005, Journal of hepatology.

[24]  S. Strasser,et al.  Clinical experience gained from the use of 120 steatotic donor livers for orthotopic liver transplantation , 2003, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[25]  M. Abecassis,et al.  Body mass index as a predictor of hepatic steatosis in living liver donors , 2001, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[26]  B. Zauscher,et al.  Omega-3 fatty acids improve hepatic steatosis in a murine model: potential implications for the marginal steatotic liver donor. , 2005, Transplantation.

[27]  A. Marcos,et al.  Adult living donor liver transplantation: who is the ideal donor and recipient? , 2005, Journal of hepatology.

[28]  T. Howard,et al.  Selecting the donor liver: Risk factors for poor function after orthotopic liver transplantation , 1994, Hepatology.

[29]  H. Bismuth,et al.  Effects of 10 Minutes of Ischemic Preconditioning of the Cadaveric Liver on the Graft's Preservation and Function: The Ying and the Yang , 2005, Annals of surgery.

[30]  J. Buckels,et al.  Impact of donor liver microvesicular steatosis on the outcome of liver retransplantation. , 1999, Transplantation proceedings.

[31]  J. Galanko,et al.  Impact of Donor Age and Year of Transplant on Graft Survival in Liver Transplant Recipients with Chronic Hepatitis C , 2004, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[32]  R. Stratta,et al.  FROZEN SECTION EVALUATION OF DONOR LIVERS BEFORE TRANSPLANTATION , 1993, Transplantation.

[33]  D. Pessayre,et al.  Inhibition of mitochondrial beta-oxidation as a mechanism of hepatotoxicity. , 1995, Pharmacology & therapeutics.

[34]  D. Samuel,et al.  Liver transplantation for hepatitis B virus-related liver disease: indications, prevention of recurrence and results. , 2003, Journal of hepatology.

[35]  Miguel Angel García Ureña,et al.  Hepatic Steatosis in Liver Transplant Donors: Common Feature of Donor Population? , 1998, World Journal of Surgery.

[36]  A. Sheil,et al.  Donor fatty (steatotic) liver allografts in orthotopic liver transplantation. , 1998, Transplantation proceedings.

[37]  H. Rüdiger,et al.  A Prospective Randomized Study in 100 Consecutive Patients Undergoing Major Liver Resection With Versus Without Ischemic Preconditioning , 2003, Annals of surgery.

[38]  S. Knechtle,et al.  The predictive value of donor liver biopsies for the development of primary nonfunction after orthotopic liver transplantation. , 1991, Transplantation.

[39]  J. Jessurun,et al.  Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease. , 2005, The Journal of clinical investigation.